Showing 101 - 120 results of 408 for search '"HPV"', query time: 0.06s Refine Results
  1. 101
  2. 102
  3. 103
  4. 104

    Impact of social determinants and medical mistrust on parent-child HPV vaccination in economically disadvantaged communities: implications for cancer prevention by Marcelo M. Sleiman, Mary Rose Yockel, Mingqian Liu, Joanne Wendolowski, Lucile L. Adams-Campbell, Chiranjeev Dash, Lisa Carter-Bawa, Abraham Aragones, Sahana Arumani, Kenneth P. Tercyak

    Published 2025-01-01
    “…IntroductionHuman papillomavirus (HPV) vaccination and intentions, their correlates, and barriers among age-eligible parents and their children living in very economically disadvantaged communities were assessed.MethodsParents (N=198; 45% Black, 42% Latine, 57% educated <=high school [HS], 74% income <$60k annually) with children ages 10-17 from Washington, DC and Hackensack, NJ were intercepted at community events and surveyed.ResultsAmong age-eligible parents, 20% were vaccinated against HPV. …”
    Get full text
    Article
  5. 105
  6. 106

    Burden of HPV-induced diseases and cost effectiveness of catch-up vaccination in Czech Republic: a model-based study by Vojtech Kamenský, Lukáš Dostálek, Martin Rožánek, Aleš Tichopád, Roman Prymula, Ivana Šarkanová

    Published 2025-02-01
    “…Abstract Objectives Human papillomavirus (HPV) infections are highly prevalent sexually transmitted infections, notably associated with various cancers. …”
    Get full text
    Article
  7. 107
  8. 108
  9. 109
  10. 110
  11. 111
  12. 112
  13. 113

    Nationwide cervical precancer screening in Ghana: concurrent HPV DNA testing and visual inspection under an expanded hub-and-spoke model by Kofi Effah, John Allotey, Ethel Tekpor, Comfort Mawusi Wormenor, Joseph Emmanuel Amuah, Ernest Antwi-Boasiako, Erasmus Nikoi Kotey, Seyram Kemawor, Isaac Gedzah, Helena Maame Ama Frempong, Stephen Danyo, Edna Sesenu, Bernard Hayford Atuguba, Nana Owusu Mensah Essel, Patrick Kafui Akakpo

    Published 2025-01-01
    “…The most frequently detected HPV genotype was other hr-HPV type(s) only (non-HPV16, non-HPV18) (23.5%; 95% CI 22.3–24.7), followed by HPV16 only (1.5%; 95% CI 1.2–1.8), and mixed infection with HPV18 + other hr-HPV type(s) (1.2%; 95% CI 0.9–1.5). …”
    Get full text
    Article
  14. 114

    Research Status of Clustered Regulary Interspaced Short Palindromic Repeats Technology in the Treatment of Human Papillomavirus (HPV) Infection Related Diseases by Minxue Tang MD

    Published 2025-01-01
    “…Research Design: This article provides an overview of the advancements made in utilizing the CRISPR-Cas9 system as a research tool for HPV-related treatments while summarizing its application status in basic research, diagnosis, and treatment of HPV. …”
    Get full text
    Article
  15. 115
  16. 116
  17. 117

    HPV16E6-Dependent c-Fos Expression Contributes to AP-1 Complex Formation in SiHa Cells by Feixin Liang, Shinichiro Kina, Hiroyuki Takemoto, Akira Matayoshi, Thongsavanh Phonaphonh, Nao Sunagawa, Keiichi Arakaki, Akira Arasaki, Hai Kuang, Hajime Sunakawa

    Published 2011-01-01
    “…Here, we show that HPV16E6-dependent c-fos oncogenic protein expression contributes to AP-1 complex formation under oxidative stress in SiHa cells (HPV16-positive squamous cell carcinoma of the cervix). …”
    Get full text
    Article
  18. 118

    Pathways and processes to adopting or switching to a single-dose HPV vaccination schedule in low- and middle-income countries: a qualitative study. by Sunny Roy, Megan D Wysong, Erica N Rosser, Ishani Sheth, Casey Geddes, Rupali J Limaye, Joseph G Rosen

    Published 2025-01-01
    “…We identified six key sequential steps LMICs follow when deciding on an HPV dosing schedule. Firstly, the new recommendation emerges where WHO and the Strategic Advisory Group of Experts (SAGE) release new HPV vaccine recommendations. …”
    Get full text
    Article
  19. 119
  20. 120

    Community-based HPV self-collection versus visual inspection with acetic acid in Uganda: a cost-effectiveness analysis of the ASPIRE trial by Joel Singer, Angeli Rawat, Heather Armstrong, Josaphat Byamugisha, Gina S Ogilvie, Alex K Mezei, Heather N Pedersen, Stephen Sy, Catherine Regan, Sheona M Mitchell-Foster, Musa Sekikubo, Jane J Kim, Nicole G Campos

    Published 2018-06-01
    “…The trial compared screening uptake and compliance with follow-up in two arms: (1) community-based (ie, home or workplace) self-collected HPV testing (facilitated by community health workers) with clinic-based visual inspection with acetic acid (VIA) triage of HPV-positive women (‘HPV-VIA’) and (2) clinic-based VIA (‘VIA’). …”
    Get full text
    Article